House Resolution 295 has just been introduced by StopAfib.org's home district representative, Congresswoman Kay Granger (R-TX). We would like to thank Representative Granger for her support of the atrial fibrillation community. The AF Resolution encourages promotion of afib awareness, diagnosis, and treatment. To move the resolution out of committee and to the House floor for …
Read More
At the recent Boston Atrial Fibrillation Symposium, catheter ablation was presented as possibly a better atrial fibrillation (AF) treatment option for serious and professional athletes than antiarrhythmic drugs (AADs). According to Dr. Riccardo Cappato (Institute Policlinics San Donato, Milan, Italy), antiarrhythmic drug therapy has not been popular with this patient population."Even when effective, AADs significantly …
Read More
At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm at Boston Atrial …
Read More
If you have a problem getting Medicare, Medicare Advantage, or your health insurance plan to cover an atrial fibrillation treatment, such as an afib medication, catheter ablation, or mini maze surgery, you don’t have to take "no" for an answer. You can push back by requesting a "coverage determination" or submitting an appeal. To learn …
Read More
RECORD AF registry findings were presented at the American Heart Association Scientific Sessions. This registry looked at how newly-diagnosed afib patients were being managed in the real world. These results differed from previously-reported research, such as the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) trial. In the real world, more cardiologists chose rhythm drugs …
Read More
A newly published study reports on a type of cell found in the upper chamber (atrium) of the heart and in the pulmonary veins that triggers atrial fibrillation. Like the skin cells that make pigment, the afib-trigger cells produce an enzyme called DCT. Researchers hope this discovery will lead to new research and effective atrial …
Read More
Through the American Recovery and Reinvestment Act of 2009, the US federal government has allocated $1.1 billion for research into the comparative effectiveness of different medical treatments. New reports just out prioritize atrial fibrillation treatment on this comparative effectiveness research agenda. Comparative effectiveness research has the potential to improve atrial fibrillation patient treatment and save …
Read More
The "Out of Sync: The State of Afib in America" survey compared the perspectives of patients who have been diagnosed with afib, and the physicians and nurses who treat afib patients. The results revealed a clear disconnect between medical professionals and patients about their understanding of afib risks. According to the survey: Less than half …
Read More
Please join us for an Atrial Fibrillation Patient Program, Dinner with the Doctor, in Hollywood, FL on Wednesday, April 15, 2009. Featured speakers are Dr. Michael Cortelli, Surgeon and Mellanie True Hills, CEO of StopAfib.org. Details at: Dinner with the Doctor
Read More
The NY Times has a fascinating story about Elderspeak and how it can jeopardize your health. Read more, including what it means for those with atrial fibrillation, at Speak Up to Get the Atrial Fibrillation Treatment You Deserve Then please come back over here to the blog and post your comments below. I am confident …
Read More